About
Tim has nearly thirty years' experience in the medical products and biotechnology fields in both corporate management and venture capital. Mr. Wollaeger joined Sanderling as a Managing Director in 2002, as head of the firm's San Diego office. Mr. Wollaeger began his career at Baxter International where his last position was Vice President and General Manager of the Company's operations in Mexico. In 1983 he joined Hybritech, Inc., San Diego's first biotechnology company, as Vice President and Chief Financial Officer. Following Hybritech's acquisition by Eli Lilly & Co in 1986, he became a founding General Partner of Biovest, a San Diego based venture capital firm. At Biovest, he helped found and remained an active Board member in Pyxis, Vical and Biosite. All three of these companies became public and Pyxis was acquired by Cardinal Health in 1996 for a $1 billion. He then helped found Columbia Hospital Corporation in 1990 and was a Senior Vice President and member of the Board of
Position in the VCSift Database
- • 7 investors at Sanderling Ventures are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Timothy Wollaeger is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
Find more investors like Timothy
Search Investors